Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SELECT trial of perioperative selective digestive decontamination in elective colorectal cancer surgery
2011-002211-28Phase 3Completed
- Sponsor
- Amsterdam University Medical Center
- Start
- Nov 2012
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 3, randomised trial of colistin, tobramycin and amphotericin b in colorectal cancer (CRC) (2 arms), sponsored by Amsterdam University Medical Center. Primary endpoint: Anastomotic leakage and/or anastomotic abscess. Started Nov 2012; status: completed.
02
Drugs
colistintobramycinamphotericin b
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on 2011-002211-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-002211-28.